NF2 and NF2-related schwannomatosis: It effectively represents a whole population study of NF2 patients with all NF2 patients being managed by just 4 centers.7,28 This is likely to represent extremely high ascertainment with no patients being totally lost to follow-up and deaths identified for all patients through the NHS registry system.